Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 7/20 | 0.59 |
| ▸ | FABP3 | P05413 | 3/20 | 0.59 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 6/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.58 |
| ▸ | TDP2 | O95551 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.58 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29967042 | 0.97 | FABP4 (0.63) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL5187548 | 0.97 | FABP4 (0.63) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL11602683 | 0.95 | FABP4 (0.61) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL13065508 | 0.88 | CDC25B (0.59) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL16784748 | 0.87 | FABP4 (0.53) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL13021513 | 0.87 | FABP4 (0.56) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL11849832 | 0.87 | MAPT (0.54) | ALDH1A1L3MBTL1FABP4FABP3FABP5 | |
| SCHEMBL9170104 | 0.85 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1FABP4FABP3MAPT | |
| SCHEMBL42481 | 0.85 | MAPT (0.71) | ALDH1A1L3MBTL1MAPTKMT2AKDM4E | |
| SCHEMBL29438168 | 0.85 | MAPT (0.71) | ALDH1A1L3MBTL1MAPTKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0576995-B1 | Process for the preparation of 5-halogeno-2-(1-anthraquinonylamino)benzoic acids and of 4'-halogeno-2,1(N)-anthraquinonyl-1',2'(N)-benzacridones | BASF AG (DE) | 1997-09-17 | — | — | EP | claimed |
| US-5401846-A | Synthesis of vat dyes | BASF AKTIENGESELLSCHAFT (DE) | 1995-03-28 | — | — | US | claimed |
| JP-6065170-A | — | — | None | — | — | JP | disclosed |
| US-20070232622-A1 | Small molecule toll-like receptor (TLR) antagonists | COLEY PHARMACEUTICAL GMBH (DE) | 2007-10-04 | — | — | US | disclosed |
| US-20070232622-A1 | Small molecule toll-like receptor (TLR) antagonists | COLEY PHARMACEUTICAL GMBH (DE) | 2007-10-04 | — | — | US | disclosed |
| CN-1245516-A | Method for preparing light-absorbing polymer composition | EASTMAN CHEM CO (US) | 2000-02-23 | — | — | CN | disclosed |
| EP-0948570-A1 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1998048769-A1 | UV-CURABLE NAIL COATING FORMULATIONS CONTAINING CELLULOSE ESTERS WITH ETHYLENICALLY UNSATURATED PENDANT GROUPS | EASTMAN CHEMICAL COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998023690-A9 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | — | 1998-09-17 | — | — | WO | disclosed |
| WO-1998023690-A1 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| EP-0703945-A1 | CELLULOSE ESTER BLENDS | EASTMAN CHEMICAL COMPANY (US) | 1996-04-03 | — | — | EP | disclosed |
| US-5401846-A | Synthesis of vat dyes | BASF AKTIENGESELLSCHAFT (DE) | 1995-03-28 | — | — | US | disclosed |
| US-5401846-A | Synthesis of vat dyes | BASF AKTIENGESELLSCHAFT (DE) | 1995-03-28 | — | — | US | disclosed |
| WO-1994028062-A1 | CELLULOSE ESTER BLENDS | EASTMAN CHEMICAL COMPANY (US) | 1994-12-08 | — | — | WO | disclosed |
| JP-H0665170-A | PREPARATION OF 5-HALOGEN-2-(1-ANTHRAQUINONYLAMINO) BENZOIC ACID AND 4'-HALOGEN-2,1(N)-ANTHRAQUINONYL-1',2'(N) BENZACRIDONE | BASF AG | 1994-03-08 | — | — | JP | disclosed |
| EP-0576995-A2 | Process for the preparation of 5-halogeno-2-(1-anthraquinonylamino)benzoic acids and of 4'-halogeno-2,1(N)-anthraquinonyl-1',2'(N)-benzacridones | BASF Aktiengesellschaft (DE) | 1994-01-05 | — | — | EP | disclosed |
| EP-0570511-A1 | THERMOPLASTIC POLYMERS COLORED WITH POLYESTER COLOR CONCENTRATES | EASTMAN CHEMICAL COMPANY (US) | 1993-11-24 | — | — | EP | disclosed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1992013921-A1 | THERMOPLASTIC POLYMERS COLORED WITH POLYESTER COLOR CONCENTRATES | EASTMAN KODAK COMPANY (US) | 1992-08-20 | — | — | WO | disclosed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232622-A1 | Small molecule toll-like receptor (TLR) antagonists | TLR3, TLR8, TLR7 | ALDH1A1 4582/4885L3MBTL1 792/4885FABP4 3034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.